Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc operates in various business sectors.
Amphastar Pharmaceuticals Inc (29A) - Total Assets
Latest total assets as of June 2024: €1.49 Billion EUR
Based on the latest financial reports, Amphastar Pharmaceuticals Inc (29A) holds total assets worth €1.49 Billion EUR as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Amphastar Pharmaceuticals Inc - Total Assets Trend (2018–2023)
This chart illustrates how Amphastar Pharmaceuticals Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Amphastar Pharmaceuticals Inc - Asset Composition Analysis
Current Asset Composition (December 2023)
Amphastar Pharmaceuticals Inc's total assets of €1.49 Billion consist of 32.4% current assets and 67.6% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 9.5% |
| Accounts Receivable | €114.94 Million | 7.6% |
| Inventory | €105.83 Million | 7.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €610.08 Million | 40.3% |
| Goodwill | €3.22 Million | 0.2% |
Asset Composition Trend (2018–2023)
This chart illustrates how Amphastar Pharmaceuticals Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Amphastar Pharmaceuticals Inc's current assets represent 32.4% of total assets in 2023, a decrease from 42.9% in 2018.
- Cash Position: Cash and equivalents constituted 9.5% of total assets in 2023, down from 16.8% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 40.0% of total assets, an increase from 7.0% in 2018.
- Asset Diversification: The largest asset category is intangible assets at 40.3% of total assets.
Amphastar Pharmaceuticals Inc Competitors by Total Assets
Key competitors of Amphastar Pharmaceuticals Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
| No similar companies found. | ||
Amphastar Pharmaceuticals Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Amphastar Pharmaceuticals Inc generates 0.43x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Amphastar Pharmaceuticals Inc generates $9.09 in net profit.
Amphastar Pharmaceuticals Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.52 | 1.53 | 3.10 |
| Quick Ratio | 2.63 | 1.11 | 2.08 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €345.67 Million | € 133.27 Million | € 205.68 Million |
Amphastar Pharmaceuticals Inc - Advanced Valuation Insights
This section examines the relationship between Amphastar Pharmaceuticals Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 103.9% |
| Total Assets | €1.51 Billion |
| Market Capitalization | $147.17K USD |
Valuation Analysis
Below Book Valuation: The market values Amphastar Pharmaceuticals Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Amphastar Pharmaceuticals Inc's assets grew by 103.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Amphastar Pharmaceuticals Inc (2018–2023)
The table below shows the annual total assets of Amphastar Pharmaceuticals Inc from 2018 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €1.51 Billion | +103.90% |
| 2022-12-31 | €741.99 Million | +10.49% |
| 2021-12-31 | €671.53 Million | +6.38% |
| 2020-12-31 | €631.24 Million | +7.54% |
| 2019-12-31 | €586.97 Million | +14.29% |
| 2018-12-31 | €513.56 Million | -- |